Dicyclomine Hydrochloride
Product Images NDC 10135-520

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Dicyclomine Hydrochloride (NDC 10135-520). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Marlex Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

The Following Structural Formula For Dicyclomine Hydrochloride Is [bicyclohexyl]-1-carboxylic Acid, 2- (diethylamino) Ethyl Ester, Hydrochloride, With A Molecular Formula Of C19h35no2•hcl. (Dicyclomine 01)

FDA Label Image

Principal Display Panelndc 10135-0520-10dicyclomine Hydrochloridecapsules, Usp10 mgrx Only1000 Capsules (Dicyclomine 02)

Principal Display Panelndc 10135-0520-10dicyclomine Hydrochloridecapsules, Usp10 mgrx Only1000 Capsules (Dicyclomine 02)
This is a description of Dicyclomine Hydrochloride Capsules manufactured and distributed by Marlex Pharmaceuticals, Inc. The capsules are only available with a prescription and come in a container containing 1000 capsules, with each capsule containing 10mg of dicyclomine hydrochloride. The recommended dosage can be found in the package insert. The capsules should be kept in a well-closed container at controlled room temperature (20°C to 25°C or 68°F to 77°F), as defined in the USP.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.